跳轉至內容
Merck
  • [Research progress on the efficacy, metabolism and bioavailability of mebendazole in hydatid disease].

[Research progress on the efficacy, metabolism and bioavailability of mebendazole in hydatid disease].

Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases (2010-03-18)
Cong-Shan Liu, Hao-Bing Zhang
摘要

Mebendazole is currently used in the treatment of hydatid disease. Its poor absorption from the gastrointestinal tract and low bioavailability aroused further research on new formulations of mebendazole to increase the bioavailability and improve the therapeutic efficacy. This review summarizes the recent research progress.

材料
產品編號
品牌
產品描述

USP
甲苯咪唑, United States Pharmacopeia (USP) Reference Standard
Supelco
甲苯咪唑, analytical standard, ≥98% (HPLC)
Supelco
甲苯咪唑, VETRANAL®, analytical standard
甲苯咪唑, European Pharmacopoeia (EP) Reference Standard
甲苯咪唑, European Pharmacopoeia (EP) Reference Standard